nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—AR—scrotum—colon cancer	0.13	0.416	CbGeAlD
Fludrocortisone—AR—Regulation of Androgen receptor activity—SPDEF—colon cancer	0.0257	0.0757	CbGpPWpGaD
Fludrocortisone—Muscle atrophy—Vincristine—colon cancer	0.0239	0.0718	CcSEcCtD
Fludrocortisone—Aseptic necrosis—Methotrexate—colon cancer	0.0237	0.0712	CcSEcCtD
Fludrocortisone—NR3C2—Preimplantation Embryo—CDX2—colon cancer	0.0205	0.0604	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—SPDEF—colon cancer	0.0195	0.0574	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDX1—colon cancer	0.0157	0.0463	CbGpPWpGaD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.0146	0.0432	CbGpPWpGaD
Fludrocortisone—NR3C2—smooth muscle tissue—colon cancer	0.0134	0.0428	CbGeAlD
Fludrocortisone—NR3C2—renal system—colon cancer	0.0129	0.0412	CbGeAlD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—RAD54L—colon cancer	0.0111	0.0328	CbGpPWpGaD
Fludrocortisone—NR3C2—digestive system—colon cancer	0.0106	0.0338	CbGeAlD
Fludrocortisone—AR—epithelium—colon cancer	0.0103	0.0329	CbGeAlD
Fludrocortisone—AR—smooth muscle tissue—colon cancer	0.00994	0.0317	CbGeAlD
Fludrocortisone—AR—renal system—colon cancer	0.00957	0.0305	CbGeAlD
Fludrocortisone—NR3C2—vagina—colon cancer	0.00936	0.0299	CbGeAlD
Fludrocortisone—NR3C1—embryo—colon cancer	0.00916	0.0292	CbGeAlD
Fludrocortisone—Skin hyperpigmentation—Fluorouracil—colon cancer	0.00881	0.0265	CcSEcCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—TGFB1—colon cancer	0.0087	0.0257	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptors—HNF4A—colon cancer	0.00859	0.0253	CbGpPWpGaD
Fludrocortisone—Diabetic—Methotrexate—colon cancer	0.00817	0.0246	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—AXIN2—colon cancer	0.00804	0.0237	CbGpPWpGaD
Fludrocortisone—AR—lymphoid tissue—colon cancer	0.00795	0.0254	CbGeAlD
Fludrocortisone—NR3C2—liver—colon cancer	0.0079	0.0252	CbGeAlD
Fludrocortisone—AR—digestive system—colon cancer	0.00785	0.025	CbGeAlD
Fludrocortisone—NR3C1—epithelium—colon cancer	0.00747	0.0238	CbGeAlD
Fludrocortisone—Osteonecrosis—Methotrexate—colon cancer	0.00732	0.022	CcSEcCtD
Fludrocortisone—NR3C1—smooth muscle tissue—colon cancer	0.0072	0.023	CbGeAlD
Fludrocortisone—AR—vagina—colon cancer	0.00693	0.0221	CbGeAlD
Fludrocortisone—NR3C1—renal system—colon cancer	0.00693	0.0221	CbGeAlD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.00679	0.02	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ODC1—colon cancer	0.00673	0.0198	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—HNF4A—colon cancer	0.00652	0.0192	CbGpPWpGaD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00636	0.0187	CbGpPWpGaD
Fludrocortisone—Impaired healing—Methotrexate—colon cancer	0.00631	0.019	CcSEcCtD
Fludrocortisone—Hirsutism—Capecitabine—colon cancer	0.0063	0.019	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Capecitabine—colon cancer	0.00616	0.0185	CcSEcCtD
Fludrocortisone—NR3C2—lymph node—colon cancer	0.00605	0.0193	CbGeAlD
Fludrocortisone—AR—liver—colon cancer	0.00585	0.0187	CbGeAlD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF4A—colon cancer	0.0058	0.0171	CbGpPWpGaD
Fludrocortisone—NR3C1—lymphoid tissue—colon cancer	0.00576	0.0184	CbGeAlD
Fludrocortisone—NR3C1—digestive system—colon cancer	0.00568	0.0181	CbGeAlD
Fludrocortisone—NR3C2—Preimplantation Embryo—CDH1—colon cancer	0.00547	0.0161	CbGpPWpGaD
Fludrocortisone—NR3C1—bone marrow—colon cancer	0.00524	0.0167	CbGeAlD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.00515	0.0152	CbGpPWpGaD
Fludrocortisone—NR3C1—vagina—colon cancer	0.00502	0.016	CbGeAlD
Fludrocortisone—Neoplasm—Irinotecan—colon cancer	0.00495	0.0149	CcSEcCtD
Fludrocortisone—Osteoporosis—Methotrexate—colon cancer	0.00486	0.0146	CcSEcCtD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—colon cancer	0.0048	0.0142	CbGpPWpGaD
Fludrocortisone—Oesophagitis—Fluorouracil—colon cancer	0.00479	0.0144	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Fluorouracil—colon cancer	0.00476	0.0143	CcSEcCtD
Fludrocortisone—Multiple fractures—Methotrexate—colon cancer	0.00469	0.0141	CcSEcCtD
Fludrocortisone—Fracture—Methotrexate—colon cancer	0.00469	0.0141	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—HNF4A—colon cancer	0.00469	0.0138	CbGpPWpGaD
Fludrocortisone—Thrombophlebitis—Irinotecan—colon cancer	0.00459	0.0138	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Methotrexate—colon cancer	0.00458	0.0138	CcSEcCtD
Fludrocortisone—AR—lymph node—colon cancer	0.00448	0.0143	CbGeAlD
Fludrocortisone—Petechiae—Capecitabine—colon cancer	0.00445	0.0134	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Fluorouracil—colon cancer	0.0044	0.0132	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—colon cancer	0.00438	0.0129	CbGpPWpGaD
Fludrocortisone—Injury—Irinotecan—colon cancer	0.00432	0.013	CcSEcCtD
Fludrocortisone—NR3C1—liver—colon cancer	0.00424	0.0135	CbGeAlD
Fludrocortisone—Contusion—Capecitabine—colon cancer	0.0042	0.0126	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.00411	0.0121	CbGpPWpGaD
Fludrocortisone—Anaphylactoid reaction—Irinotecan—colon cancer	0.0041	0.0124	CcSEcCtD
Fludrocortisone—Cataract—Capecitabine—colon cancer	0.00385	0.0116	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—PPARG—colon cancer	0.00373	0.011	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MSH6—colon cancer	0.00366	0.0108	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Vincristine—colon cancer	0.0036	0.0108	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—colon cancer	0.00356	0.0105	CbGpPWpGaD
Fludrocortisone—Fluid retention—Capecitabine—colon cancer	0.00348	0.0105	CcSEcCtD
Fludrocortisone—Abdominal distension—Irinotecan—colon cancer	0.00346	0.0104	CcSEcCtD
Fludrocortisone—Pancreatitis—Irinotecan—colon cancer	0.00337	0.0101	CcSEcCtD
Fludrocortisone—Muscular weakness—Fluorouracil—colon cancer	0.00336	0.0101	CcSEcCtD
Fludrocortisone—Oesophagitis—Capecitabine—colon cancer	0.00335	0.0101	CcSEcCtD
Fludrocortisone—Sweating increased—Irinotecan—colon cancer	0.00334	0.0101	CcSEcCtD
Fludrocortisone—Petechiae—Methotrexate—colon cancer	0.00331	0.00998	CcSEcCtD
Fludrocortisone—Neoplasm—Capecitabine—colon cancer	0.00331	0.00997	CcSEcCtD
Fludrocortisone—Ecchymosis—Capecitabine—colon cancer	0.00331	0.00997	CcSEcCtD
Fludrocortisone—NR3C1—lymph node—colon cancer	0.00325	0.0104	CbGeAlD
Fludrocortisone—Thrombophlebitis—Capecitabine—colon cancer	0.00307	0.00924	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Capecitabine—colon cancer	0.00306	0.0092	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MSH2—colon cancer	0.00297	0.00876	CbGpPWpGaD
Fludrocortisone—Vascular purpura—Capecitabine—colon cancer	0.00297	0.00895	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00295	0.00869	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—PPARG—colon cancer	0.00283	0.00835	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.00281	0.00827	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—SRC—colon cancer	0.00279	0.00824	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Irinotecan—colon cancer	0.00276	0.00831	CcSEcCtD
Fludrocortisone—Purpura—Capecitabine—colon cancer	0.00276	0.0083	CcSEcCtD
Fludrocortisone—Haemorrhage—Irinotecan—colon cancer	0.00275	0.00827	CcSEcCtD
Fludrocortisone—Haemoglobin—Fluorouracil—colon cancer	0.00265	0.00796	CcSEcCtD
Fludrocortisone—Haemorrhage—Fluorouracil—colon cancer	0.00263	0.00792	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—HNF4A—colon cancer	0.00253	0.00745	CbGpPWpGaD
Fludrocortisone—Mood swings—Capecitabine—colon cancer	0.00252	0.00758	CcSEcCtD
Fludrocortisone—Neoplasm—Methotrexate—colon cancer	0.00247	0.00742	CcSEcCtD
Fludrocortisone—Ecchymosis—Methotrexate—colon cancer	0.00247	0.00742	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.00236	0.00696	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Capecitabine—colon cancer	0.00235	0.00706	CcSEcCtD
Fludrocortisone—Abdominal distension—Capecitabine—colon cancer	0.00231	0.00696	CcSEcCtD
Fludrocortisone—Erythema—Fluorouracil—colon cancer	0.00229	0.0069	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Methotrexate—colon cancer	0.00229	0.00688	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Methotrexate—colon cancer	0.00228	0.00685	CcSEcCtD
Fludrocortisone—Sweating increased—Capecitabine—colon cancer	0.00224	0.00674	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00224	0.0066	CbGpPWpGaD
Fludrocortisone—Vertigo—Vincristine—colon cancer	0.00221	0.00664	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—EP300—colon cancer	0.00217	0.0064	CbGpPWpGaD
Fludrocortisone—Vertigo—Irinotecan—colon cancer	0.00215	0.00647	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—colon cancer	0.00213	0.00628	CbGpPWpGaD
Fludrocortisone—Convulsion—Vincristine—colon cancer	0.00213	0.00641	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—PIK3CA—colon cancer	0.00213	0.00627	CbGpPWpGaD
Fludrocortisone—Hypertension—Vincristine—colon cancer	0.00212	0.00638	CcSEcCtD
Fludrocortisone—Megestrol acetate—ABCB1—colon cancer	0.00211	0.14	CrCbGaD
Fludrocortisone—Myalgia—Vincristine—colon cancer	0.00209	0.0063	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—BAX—colon cancer	0.00208	0.00613	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Capecitabine—colon cancer	0.00207	0.00624	CcSEcCtD
Fludrocortisone—Hypertension—Irinotecan—colon cancer	0.00207	0.00622	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—EP300—colon cancer	0.00206	0.00607	CbGpPWpGaD
Fludrocortisone—Anaphylactoid reaction—Methotrexate—colon cancer	0.00205	0.00616	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Vincristine—colon cancer	0.00201	0.00603	CcSEcCtD
Fludrocortisone—Oedema—Vincristine—colon cancer	0.00201	0.00603	CcSEcCtD
Fludrocortisone—Infection—Vincristine—colon cancer	0.00199	0.006	CcSEcCtD
Fludrocortisone—Convulsion—Fluorouracil—colon cancer	0.00199	0.00598	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—HRAS—colon cancer	0.00197	0.0058	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—colon cancer	0.00196	0.00578	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Irinotecan—colon cancer	0.00195	0.00588	CcSEcCtD
Fludrocortisone—Oedema—Irinotecan—colon cancer	0.00195	0.00588	CcSEcCtD
Fludrocortisone—Myalgia—Fluorouracil—colon cancer	0.00195	0.00587	CcSEcCtD
Fludrocortisone—Infection—Irinotecan—colon cancer	0.00194	0.00584	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Vincristine—colon cancer	0.00194	0.00583	CcSEcCtD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—colon cancer	0.00189	0.00558	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.00189	0.00557	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Irinotecan—colon cancer	0.00189	0.00568	CcSEcCtD
Fludrocortisone—Mood swings—Methotrexate—colon cancer	0.00188	0.00564	CcSEcCtD
Fludrocortisone—AR—Regulation of Androgen receptor activity—EP300—colon cancer	0.00187	0.00552	CbGpPWpGaD
Fludrocortisone—Oedema—Fluorouracil—colon cancer	0.00187	0.00563	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Fluorouracil—colon cancer	0.00187	0.00563	CcSEcCtD
Fludrocortisone—Infection—Fluorouracil—colon cancer	0.00186	0.00559	CcSEcCtD
Fludrocortisone—Haemoglobin—Capecitabine—colon cancer	0.00185	0.00556	CcSEcCtD
Fludrocortisone—NR3C1—Endoderm Differentiation—APC—colon cancer	0.00184	0.00543	CbGpPWpGaD
Fludrocortisone—Haemorrhage—Capecitabine—colon cancer	0.00184	0.00554	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Vincristine—colon cancer	0.00183	0.0055	CcSEcCtD
Fludrocortisone—AR—Regulation of Androgen receptor activity—SRC—colon cancer	0.00182	0.00536	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CCND1—colon cancer	0.00182	0.00535	CbGpPWpGaD
Fludrocortisone—Insomnia—Vincristine—colon cancer	0.00181	0.00546	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CTNNB1—colon cancer	0.0018	0.0053	CbGpPWpGaD
Fludrocortisone—Insomnia—Irinotecan—colon cancer	0.00177	0.00532	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—AKT1—colon cancer	0.00174	0.00512	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.0017	0.00513	CcSEcCtD
Fludrocortisone—Insomnia—Fluorouracil—colon cancer	0.00169	0.00509	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BAX—colon cancer	0.00168	0.00496	CbGpPWpGaD
Fludrocortisone—Pancreatitis—Methotrexate—colon cancer	0.00168	0.00505	CcSEcCtD
Fludrocortisone—Methylprednisolone—ABCB1—colon cancer	0.00162	0.107	CrCbGaD
Fludrocortisone—Triamcinolone—PTGS2—colon cancer	0.00161	0.106	CrCbGaD
Fludrocortisone—Erythema—Capecitabine—colon cancer	0.0016	0.00482	CcSEcCtD
Fludrocortisone—Urticaria—Fluorouracil—colon cancer	0.00149	0.00447	CcSEcCtD
Fludrocortisone—Hypersensitivity—Vincristine—colon cancer	0.00148	0.00445	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.00147	0.00435	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—colon cancer	0.00146	0.00431	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—colon cancer	0.00145	0.00427	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.00145	0.00427	CbGpPWpGaD
Fludrocortisone—Vertigo—Capecitabine—colon cancer	0.00144	0.00433	CcSEcCtD
Fludrocortisone—Hypersensitivity—Irinotecan—colon cancer	0.00144	0.00433	CcSEcCtD
Fludrocortisone—Asthenia—Vincristine—colon cancer	0.00144	0.00433	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—EP300—colon cancer	0.00142	0.00418	CbGpPWpGaD
Fludrocortisone—Asthenia—Irinotecan—colon cancer	0.0014	0.00422	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	0.0014	0.00413	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.00139	0.00411	CbGpPWpGaD
Fludrocortisone—Hypertension—Capecitabine—colon cancer	0.00138	0.00416	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—SRC—colon cancer	0.00138	0.00407	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—EP300—colon cancer	0.00138	0.00406	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Fluorouracil—colon cancer	0.00138	0.00415	CcSEcCtD
Fludrocortisone—Haemoglobin—Methotrexate—colon cancer	0.00138	0.00414	CcSEcCtD
Fludrocortisone—Haemorrhage—Methotrexate—colon cancer	0.00137	0.00412	CcSEcCtD
Fludrocortisone—Myalgia—Capecitabine—colon cancer	0.00136	0.0041	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—colon cancer	0.00135	0.00397	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CCND1—colon cancer	0.00134	0.00396	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	0.00133	0.00393	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CTNNB1—colon cancer	0.00133	0.00392	CbGpPWpGaD
Fludrocortisone—Betamethasone—PTGS2—colon cancer	0.00132	0.0869	CrCbGaD
Fludrocortisone—Spironolactone—ABCB1—colon cancer	0.00131	0.0868	CrCbGaD
Fludrocortisone—Oedema—Capecitabine—colon cancer	0.00131	0.00393	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—CDKN1A—colon cancer	0.0013	0.00383	CbGpPWpGaD
Fludrocortisone—Infection—Capecitabine—colon cancer	0.0013	0.00391	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Capecitabine—colon cancer	0.00126	0.0038	CcSEcCtD
Fludrocortisone—Headache—Vincristine—colon cancer	0.00126	0.00378	CcSEcCtD
Fludrocortisone—NR3C1—Endoderm Differentiation—CTNNB1—colon cancer	0.00125	0.00369	CbGpPWpGaD
Fludrocortisone—Prednisone—ABCB1—colon cancer	0.00124	0.0818	CrCbGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—EP300—colon cancer	0.00124	0.00364	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CCND1—colon cancer	0.00123	0.00364	CbGpPWpGaD
Fludrocortisone—Headache—Irinotecan—colon cancer	0.00122	0.00368	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CTNNB1—colon cancer	0.00122	0.0036	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—HNF4A—colon cancer	0.00122	0.00359	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BRAF—colon cancer	0.00121	0.00355	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—SRC—colon cancer	0.0012	0.00354	CbGpPWpGaD
Fludrocortisone—Erythema—Methotrexate—colon cancer	0.00119	0.00359	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00119	0.00358	CcSEcCtD
Fludrocortisone—Insomnia—Capecitabine—colon cancer	0.00118	0.00356	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CDH1—colon cancer	0.00118	0.00348	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—HNF4A—colon cancer	0.00117	0.00346	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—colon cancer	0.00117	0.00346	CbGpPWpGaD
Fludrocortisone—Headache—Fluorouracil—colon cancer	0.00117	0.00353	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	0.00116	0.00342	CbGpPWpGaD
Fludrocortisone—Prednisolone—ABCB1—colon cancer	0.00114	0.0754	CrCbGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—EP300—colon cancer	0.00114	0.00335	CbGpPWpGaD
Fludrocortisone—Betamethasone—ABCB1—colon cancer	0.00112	0.0739	CrCbGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PPARG—colon cancer	0.0011	0.00324	CbGpPWpGaD
Fludrocortisone—Vertigo—Methotrexate—colon cancer	0.00107	0.00322	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	0.00106	0.00313	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.00106	0.00313	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—PPARG—colon cancer	0.00106	0.00312	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—EGFR—colon cancer	0.00105	0.00311	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—colon cancer	0.00105	0.0031	CbGpPWpGaD
Fludrocortisone—Urticaria—Capecitabine—colon cancer	0.00104	0.00312	CcSEcCtD
Fludrocortisone—Convulsion—Methotrexate—colon cancer	0.00103	0.00311	CcSEcCtD
Fludrocortisone—Myalgia—Methotrexate—colon cancer	0.00101	0.00305	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	0.00101	0.00298	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—TGFB1—colon cancer	0.00101	0.00298	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—AKT1—colon cancer	0.00101	0.00298	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—EP300—colon cancer	0.001	0.00295	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	0.000995	0.00293	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MYC—colon cancer	0.00099	0.00292	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TGFB1—colon cancer	0.000988	0.00291	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Methotrexate—colon cancer	0.000973	0.00293	CcSEcCtD
Fludrocortisone—Infection—Methotrexate—colon cancer	0.000967	0.00291	CcSEcCtD
Fludrocortisone—Hypersensitivity—Capecitabine—colon cancer	0.000963	0.0029	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Methotrexate—colon cancer	0.000941	0.00283	CcSEcCtD
Fludrocortisone—Asthenia—Capecitabine—colon cancer	0.000938	0.00282	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CASP3—colon cancer	0.000904	0.00266	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—HNF4A—colon cancer	0.00089	0.00262	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000886	0.00267	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	0.000881	0.0026	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CASP3—colon cancer	0.00088	0.0026	CbGpPWpGaD
Fludrocortisone—Insomnia—Methotrexate—colon cancer	0.00088	0.00265	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CCND1—colon cancer	0.00088	0.00259	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—ABCB1—colon cancer	0.000873	0.0577	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	0.000871	0.00257	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.000849	0.0025	CbGpPWpGaD
Fludrocortisone—Headache—Capecitabine—colon cancer	0.000819	0.00246	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TP53—colon cancer	0.000813	0.0024	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EP300—colon cancer	0.00081	0.00239	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000807	0.00238	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	0.000805	0.00237	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—EP300—colon cancer	0.000789	0.00233	CbGpPWpGaD
Fludrocortisone—Urticaria—Methotrexate—colon cancer	0.000773	0.00233	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—VEGFA—colon cancer	0.000767	0.00226	CbGpPWpGaD
Fludrocortisone—Dexamethasone—PTGS2—colon cancer	0.000765	0.0505	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000749	0.00221	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.000747	0.0022	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—AKT1—colon cancer	0.000747	0.0022	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—CTNNB1—colon cancer	0.000745	0.0022	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000729	0.00215	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—CDKN1A—colon cancer	0.000728	0.00215	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000722	0.00213	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Methotrexate—colon cancer	0.000717	0.00216	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—colon cancer	0.000716	0.00211	CbGpPWpGaD
Fludrocortisone—Progesterone—ABCB1—colon cancer	0.000711	0.047	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MYC—colon cancer	0.000706	0.00208	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000705	0.00208	CbGpPWpGaD
Fludrocortisone—Asthenia—Methotrexate—colon cancer	0.000698	0.0021	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EGFR—colon cancer	0.00069	0.00203	CbGpPWpGaD
Fludrocortisone—Testosterone—ABCB1—colon cancer	0.000672	0.0444	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000671	0.00198	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CASP3—colon cancer	0.000668	0.00197	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000652	0.00192	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—KRAS—colon cancer	0.000652	0.00192	CbGpPWpGaD
Fludrocortisone—Dexamethasone—ABCB1—colon cancer	0.000651	0.043	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.000644	0.0019	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000635	0.00187	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—MYC—colon cancer	0.000626	0.00185	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	0.000611	0.0018	CbGpPWpGaD
Fludrocortisone—Headache—Methotrexate—colon cancer	0.000609	0.00183	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—colon cancer	0.000605	0.00178	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TGFB1—colon cancer	0.000602	0.00177	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—EP300—colon cancer	0.000598	0.00176	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000585	0.00172	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000583	0.00172	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TP53—colon cancer	0.000579	0.00171	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000572	0.00169	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.000567	0.00167	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—HNF4A—colon cancer	0.000565	0.00167	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.00054	0.00159	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PPARG—colon cancer	0.000529	0.00156	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PPARG—colon cancer	0.000509	0.0015	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000496	0.00146	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AKT1—colon cancer	0.000489	0.00144	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.00048	0.00142	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HNF4A—colon cancer	0.000429	0.00126	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000405	0.0012	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PPARG—colon cancer	0.000386	0.00114	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MYC—colon cancer	0.000301	0.000888	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—MYC—colon cancer	0.00029	0.000856	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PPARG—colon cancer	0.000245	0.000723	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—MYC—colon cancer	0.00022	0.00065	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—AKT1—colon cancer	0.000209	0.000616	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PPARG—colon cancer	0.000186	0.000548	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MYC—colon cancer	0.00014	0.000412	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MYC—colon cancer	0.000106	0.000313	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—AKT1—colon cancer	9.7e-05	0.000286	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AKT1—colon cancer	7.36e-05	0.000217	CbGpPWpGaD
